KAT2A and pancreatic ductal adenocarcinoma: Tong et al. demonstrated that KAT2A is highly expressed in human pancreatic ductal adenocarcinoma and enhances β-catenin expression to promote glycolysis in pancreatic ductal adenocarcinoma cells undergoing epithelial-to-mesenchymal transition (EMT).